These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The search for a potent DNA vaccine against AIDS: the enhancement of immunogenicity by chemical and genetic adjuvants. Sasaki S; Tsuji T; Asakura Y; Fukushima J; Okuda K Anticancer Res; 1998; 18(5D):3907-15. PubMed ID: 9854503 [TBL] [Abstract][Full Text] [Related]
23. Human vaccine testing set. AIDS Patient Care STDS; 1998 Mar; 12(3):231. PubMed ID: 11361942 [No Abstract] [Full Text] [Related]
24. Steady but slow progress toward AIDS vaccine. Minn Med; 1993 Aug; 76(8):38-9. PubMed ID: 8371702 [No Abstract] [Full Text] [Related]
25. Steering a course to an AIDS vaccine. Baltimore D Science; 2002 Jun; 296(5577):2297. PubMed ID: 12089410 [No Abstract] [Full Text] [Related]
26. Clinical trials of HIV vaccines. Graham BS Annu Rev Med; 2002; 53():207-21. PubMed ID: 11818471 [TBL] [Abstract][Full Text] [Related]
28. Development of an AIDS vaccine using Sendai virus vectors. Ishii H; Matano T Vaccine; 2015 Nov; 33(45):6061-5. PubMed ID: 26232346 [TBL] [Abstract][Full Text] [Related]
29. HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies. Chin'ombe N; Ruhanya V Pan Afr Med J; 2015; 20():386. PubMed ID: 26185576 [TBL] [Abstract][Full Text] [Related]
32. Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine. Calarota SA; Weiner DB; Lori F; Lisziewicz J Vaccine; 2007 Apr; 25(16):3070-4. PubMed ID: 17292518 [TBL] [Abstract][Full Text] [Related]
33. 'Money down the drain' fears for AIDS vaccine trials. Nature; 2003 Nov; 426(6964):220-1. PubMed ID: 14628016 [No Abstract] [Full Text] [Related]
34. HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial. Ensoli F; Cafaro A; Casabianca A; Tripiciano A; Bellino S; Longo O; Francavilla V; Picconi O; Sgadari C; Moretti S; Cossut MR; Arancio A; Orlandi C; Sernicola L; Maggiorella MT; Paniccia G; Mussini C; Lazzarin A; Sighinolfi L; Palamara G; Gori A; Angarano G; Di Pietro M; Galli M; Mercurio VS; Castelli F; Di Perri G; Monini P; Magnani M; Garaci E; Ensoli B Retrovirology; 2015 Apr; 12():33. PubMed ID: 25924841 [TBL] [Abstract][Full Text] [Related]
35. Immunization for long-term protection against AIDS using the macaque model. Kumar A; Narayan O Virology; 2001 Jun; 285(1):1-5. PubMed ID: 11414799 [No Abstract] [Full Text] [Related]
36. Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines. Robinson HL; Weinhold KJ J Infect Dis; 2006 Dec; 194(12):1625-7. PubMed ID: 17109331 [No Abstract] [Full Text] [Related]
37. South African village prepares for first HIV vaccine trial. Connett H Nat Med; 2000 Nov; 6(11):1199-200. PubMed ID: 11062516 [No Abstract] [Full Text] [Related]
38. HIV vaccine trials for Africa. AIDS Read; 2000 Sep; 10(9):524. PubMed ID: 11019443 [No Abstract] [Full Text] [Related]
39. Results of the first phase 3 trial of an AIDS vaccine. Laurence J AIDS Read; 2003 Apr; 13(4):155-6. PubMed ID: 12741363 [No Abstract] [Full Text] [Related]
40. South African AIDS Vaccine Initiative launches phase I trial. Kresge KJ IAVI Rep; 2009; 13(4):19. PubMed ID: 20225578 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]